Skip to main content
. 2020 Apr;9(2):239–245. doi: 10.21037/tlcr.2020.03.02

Table 3. Response to osimertinib.

Mutation CR/PR SD/PD P value
Activating EGFR mutation 0.001
   Not detectable 37 (75.5%) 1 (12.5%)
   Detectable 12 (24.5%) 7 (87.5%)
T790M mutation 1.0
   Not detectable 42 (86%) 7 (87.5%)
   Detectable 7 (14%) 1 (12.5%)

EGFR, epidermal growth factor receptor; CR, complete response; PR, partial response; SD, stable disease; PD, disease progression.